baber/WOPTO huggingface dataset:
Patent IL-95229-A0 (IL)
Title: Computer system
IPC: G06F9/445
Filed: 1990-07-30
Abstract: An apparatus and method for protecting BIOS stored on a direct access storage device (62) into a personal computer system (10). The personal computer system (JO) comprises a system processor (26), a system planar (24), a random access main memory (32), a read only memory (36), a protection means and at least one direct access storage device (62). The read only memory (36) includes a first portion of BIOS and data representing the type of system processor (26) and system planar (24) I/O configuration. The first portion of BIOS initializes the system (10) and the direct access storage device (62), and resets the protection means in order to read in a master boot record into the random access memory (32) from a protectable partition on the direct access storage device (62). The master boot record includes a data segment and an executable code segment. The data segment includes data representing system hardware and a system configuration which is supported by the master boot record. The first BIOS portion confirms the master boot record is compatible with the system hardware by verifying that the data from the data segment of the master boot record agrees with the system processor (26), system planar (24), and planar (24) I/O configuration. If the master boot record is compatible with the system hardware, the first BIOS portion vectors the system processor (26) to execute the executable code segment of the master boot record. The executable code segment confirms that the system configuration has not changed and loads in the remaining BIOS portion from the same protectable partition on the direct access storage device (62) into random access memory (32). The executable code segment then verifies the authenticity of the remaining BIOS portion and vectors the system processor (26) to begin executing the BIOS now in random access memory. BIOS, executing in random access memory (32), then activates the protection means to prevent further access to the protectable partition. BIOS boots up the operating system to begin operation of the personal computer system.
Patent IL-97298-A0 (IL)
Title: Vasoactive casotocin derivatives
IPC: C07K7/06
Filed: 1991-02-20
Abstract: PCT No. PCT/SE91/00154 Sec. 371 Date Sep. 23, 1992 Sec. 102(e) Date Sep. 23, 1992 PCT Filed Feb. 26, 1991 PCT Pub. No. WO91/13092 PCT Pub. Date Sep. 5, 1991.The present invention relates to new vasotocin derivatives with prolonged activity compared to previous vasotocin derivatives. In particular, the vasotocin derivatives of the present invention are of the formula (I)   <IMAGE>   wherein Hmp is a 2-hydroxy-3-mercaptopropionic acid residue,   <IMAGE>   Z is Phe or Tyr, Y is Hgn or Hci, X is a residue of the formula   <IMAGE>   wherein Q is H, alanyl or L-2-aminobutyryl and n is 1, 2 or 3. The present invention also relates to pharmaceutical compositions containing these vasotocin derivatives.
Patent IL-99525-A0 (IL)
Title: Fused ring analogs of nitrogen containing nonaromatic heterocycles
IPC: C07D413/04
Filed: 1991-09-19
Abstract: The present invention relates to novel fused ring analogs of nitrogen containing heterocycles, and specifically, to compounds of formula (I), wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8>, x, y, and z and m are defined as below. These novel compounds are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Patent SE-8301307-A0 (SE)
Title: Spärranordning med varningsskylt för gång- och fordonstrafik
Inventor: LEHTONEN TEUVO
IPC: G09F7/20
Filed: 1983-03-10
Abstract: a Sparranordning med varningsskylt for gang- och fordonstrafik avser en justerbar sakerhetsanordning att anvandas foretradesvis vid hastigt pgkomna arbeten sgsom taksnordjning, gatueller vagarbeten samt vid brand eller dylikt, dar uppmarksamhet om fara'ar pgkallat.
Patent FI-20075442-A0 (FI)
Inventor: MOISIO MARKO
IPC: B21D/
Filed: 2007-06-13
Abstract: The invention relates to a profile plate (4) for an intermediate floor. The profile plate (4) comprises a pre-stressing element (6, 12), which is fastened to the profile plate (4) in a pre-stressed state so that its pre-stressed state produces pre-stress in the profile plate (4).
Patent FI-20106079-A0 (FI)
IPC: B01D/
Filed: 2010-10-18
Abstract: A method and assembly for separating contaminants from liquids, such as condensates, or vapors at an evaporation plant. The contaminants are separated from liquids by stripping when bringing a contaminant-enriched liquid into direct contact with a vapor by spraying or distributing the liquid into the vapor flowing in a vapor duct or onto wall surfaces in the vapor duct thus reducing the contaminant-content of the sprayed liquid and producing a cleaner liquid. The contaminants are enriched in the vapor. From vapors contaminants are separated by absorption when bringing a contaminant-enriched vapor into direct contact with a cleaner liquid by spraying or distributing the liquid into the vapor flowing in a vapor duct or onto wall surfaces in the vapor duct thus increasing the contaminant-content of the liquid, but producing a cleaned vapor.
Patent FI-20115799-A0 (FI)
Inventor: DAHLEN ANDERS
IPC: H04W/
Filed: 2011-08-15
Abstract: The application relates to cell reselection, in particular for UTRAN and E-UTRA networks. The user terminal is configured to measure characteristics of radio channel of currently serving cell and neighbouring cells that are necessary for cell reselection. Typically such characteristics are measures relating to a signal strength and/or signal quality, such as CPICH RSCP, CPICH Ec/No in UTRAN, RSRP, and RSRQ in E-UTRA. However, utilization of either measure indicating signal strength or a measure indicating signal quality as a characteristic of a radio signal may cause serious problems, since e.g. in UTRAN the CPICH RSCP gives information on the coupling loss, but does not say anything on the interference. This problem is solved by configuring the mobile terminal to measure a value indicating signal strength and a value indicating signal quality as characteristics of a radio channel, i.e. the determination of a cell to be reselected is carried out by measuring values indicating signal strengths and values indicating signal quality.
Patent IL-103086-A0 (IL)
Title: Antibiotics ll-e19020 epsilon and ll-e19020 epsilon 1
IPC: C07D407/12
Filed: 1992-09-07
Abstract: The invention provides antibiotics designated LL-E19020 Epsilon and LL-E19020 Epsilon1 which are derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.
Patent IL-106644-A0 (IL)
Title: Security arrangement intended for opening and/or closing of doors,in particular for an automotive vehicle
IPC: E05B49/00
Filed: 1993-08-10
Abstract: The invention relates to a security device intended for opening and/or closing at least one door of a motor vehicle, characterised in that it includes:   - at least one operating keypad (2) built into the bodywork of the vehicle and intended for the introduction of an opening and/or closure code, the said keypad being equipped with sensor elements (6) sensitive to the touch and delivering a code corresponding to the keys activated; - a circuit (30, 32, 34, 44) capable of generating a control signal in response to the said code delivered by the control keypad; and - actuating means (36, 38) controlled by the said control signal and providing the locking and/or the unlocking of the said door.   <IMAGE>
Patent IL-111260-A0 (IL)
Title: Sports implements or parts thereof molded from epoxy resin
IPC: B29L31/52
Filed: 1994-10-12
Abstract: A sports implement or part thereof which is moulded from an epoxy resin containing at least one filler having a specific gravity (SG) below 1, and wherein the implement or part has an SG from 0.8 to 2.0.
Patent IL-112650-A0 (IL)
Title: Vocoder asic
IPC: G06F5/01
Filed: 1995-02-15
Abstract: A method and apparatus for implementing a vocoder in an application specific integrated circuit (ASIC) is disclosed. The apparatus contains a DSP core (4) that performs computations in accordance with a reduced instruction set (RISC) architecture. The circuit further comprises a specifically designed slave processor to the DSP core (4) referred to as the minimization processor (6). The feature of the invention is a specifically designed block normalization circuitry. <IMAGE>
Patent IL-119759-A0 (IL)
Title: Crop protection products
IPC: A01N65/26
Filed: 1996-12-05
Abstract: Plant protectant compositions with synergistic activity against plant diseases contains: (A) a benzothiadiazole-7-carboxylic acid derivative of formula (I) having plant immunising action; (B) a compound selected from (B1) 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-acryloyl)-morpholine (dimethomorph), (B2) 5-methyl-1,2,4-triazolo(3,4-b)(1,3)benzothiazole (tricyclazole) and (B3) 3-allyloxy-1,2-benzothiazole-1,1-dioxide (probenazole); and (C) a carrier. Z = CN, COOH (or salt), (1-4C) alkoxycarbonyl or (1-4C) alkylthiocarbonyl.
Patent IL-126626-A0 (IL)
Title: Novel antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis
IPC: A61K38/04
Filed: 1997-05-05
Abstract: Compounds of formulae (I) and (II), and their salts, esters and prodrugs, are new: A-B-C-X-Y (I); A-B1-C1-X1-Y (II); A = absent or a nitrogen-protecting group; Y = absent or a carboxy-protecting group; B = absent or 1-197 naturally occurring amino acids (aa) corresponding to residues 334-530 of the 791 aa human plasminogen (hPA) sequence given in the specification; C = Lys-R2-R3-Asp; R2 = Leu or Arg; R3 = Tyr, 3-iodotyrosinyl (ITyr) or Phe; X = absent or is 1-12 naturally occurring aa corresponding to residues 535-546 of hP and its homologues or analogues; B1 = absent or is 1-176 aa corresponding to residues 334-513 of hP; C1 = the 514-523 aa sequence of hP; X1 = absent or is 1-10 aa corresponding to residues 524-533 of hP.
Patent IL-127502-A0 (IL)
Title: Process for preparing 3-isochromanone
IPC: C07D311/76
Filed: 1997-05-21
Abstract: PCT No. PCT/GB97/01391 Sec. 371 Date Dec. 14, 1998 Sec. 102(e) Date Dec. 14, 1998 PCT Filed May 21, 1997 PCT Pub. No. WO97/48692 PCT Pub. Date Dec. 24, 19973-Isochromanone is prepared by reacting o-tolyacetic acid with sulphuryl chloride in the presence of a free radical initiator, e.g. AIBN, followed by ring closure of the 2-chloromethylphenylacetic acid so formed with a base, e.g. potassium bicarbonate.
Patent IL-128775-A0 (IL)
Title: A composition comprising a dendritic polymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
IPC: C12N15/02
Filed: 1999-03-01
Abstract: Dendritic polymer conjugates which are composed of at least one dendrimer in association with at least one unit of a carried material, where the carrier material can be a biological response modifier, have been prepared. The conjugate can also have a target director present, and when it is present then the carried material may be a bioactive agent. Preferred dendritic polymers are dense star polymers, which have been complexed with biological response modifiers. These conjugates and complexes have particularly advantageous properties due to their unique characteristics.
Patent IL-131663-A0 (IL)
Title: Ophthalmic composition
IPC: A61K47/04
Filed: 1998-03-06
Abstract: Ophthalmic composition for use in ocular surgery includes an aqueous solution of sodium hyaluronate with a concentration within the range of 18-40 mg sodium hyaluronate/ml solution and the molecular mass of sodium hyaluronate being in the range of 1x106-10x106<M>r,M. In a method for conducting ocular surgery, the composition is introduced into the eye as a surgical aid. The composition may be used in a method for conducting cataract surgery.
Patent IL-132052-A0 (IL)
Title: Wound tab condom and method of application
IPC: A61F6/04
Filed: 1998-03-06
Abstract: A condom includes a condom tubular side wall having a first side wall end and a second side wall end, the tubular side wall being rolled outwardly and over itself from the second side wall end toward the first side wall end to form a side wall roll; a condom end wall sealingly joined to the tubular side wall at the first side wall end; and at least one strip of flexible material having a gripping tab end segment with a touch distinctive tactile surface on one side thereof, the at least one strip being wound within the side wall roll so that the gripping tab end segment and touch distinctive tactile surface of the at least one strip protrudes from the side wall roll. A method of assembling the condom includes the step of winding the at least one strip together with the tubular side wall outwardly and over the tubular side wall toward the side wall second end to form a side wall roll, so that the gripping tab end segment protrudes from the side wall roll. A method of applying the condom to a penis includes the steps of grasping the tab end segment, touching the touch distinctive tactile surface thereon, orienting the condom so that the tubular side wall roll is directed away from the user, placing the condom end wall against the distal end of the penis, and pulling the tab end segment laterally outwardly from the tubular side wall, so that the side wall roll unrolls over and advances longitudinally along the penis.
Patent IL-134754-A0 (IL)
Title: N-terminally chemically modified protein compositions and methods
IPC: A61K31/00
Filed: 2000-02-27
Abstract: Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof, and resultant compositions, including novel N-terminally chemically modified G-CSF compositions and related methods of preparation. Also provided is chemically modified consensus interferon.
Patent IL-137419-A0 (IL)
Title: Nk cells activating receptors and their therapeutic and diagnostic uses
IPC: A61K39/395
Filed: 2000-07-20
Abstract: The invention relates to a targeting complex, capable of targeting an active substance to a target cell, said complex comprising: a target recognition segment comprising one of NKp46, NKp30, NKp44 or a functional fragment thereof; and an active segment comprising an active substance such as cytotoxic moiety; an imaging moiety; or an Ig fragment. The targeting complex of the invention serves as a therapeutic agents for the treatment of pathologies associated with viral infections or cancer and for the imaging and monitoring of cancer.
Patent IL-147902-A0 (IL)
Title: C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
IPC: C12N15/09
Filed: 2000-08-11
Abstract: A novel gene (designated PC-LECTIN) that is highly overexpressed in prostate cancer and its encoded protein is described. PC-LECTIN in normal human tissues is restricted to testis, but is highly expressed in prostate cancer. Consequently, PC-LECTIN provides a diagnostic and/or therapeutic target for prostate cancer.
Patent IL-149116-A0 (IL)
Title: Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
IPC: C07K16/30
Filed: 2000-10-27
Abstract: The invention provides isolated anti-prostate stem cell antigen (PSCA) antibodies that internalize upon binding to PSCA on a mammalian in vivo. The invention also encompasses compositions comprising an anti-PSCA antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-PSCA antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-PSCA antibodies. The invention encompasses a method of producing the anti-PSCA antibodies. Other aspects of the invention are a method of killing a PSCA-expressing cancer cell, comprising contacting the cancer cell with an anti-PSCA antibody and a method of alleviating or treating a PSCA-expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti-PSCA antibody to the mammal.
Patent IL-175453-A0 (IL)
Title: Use of glucosidase inhibitors for therapy of mucovisidosis
IPC: A61K31/445
Filed: 2006-05-04
Abstract: Glucosidase inhibitors are used to prepare medicaments for treating mucoviscidosis. ACTIVITY : CNS-Gen.; Respiratory-Gen. MECHANISM OF ACTION : Reactivator of cystic fibrosis transmembrane conductance regulator (CFTR) protein delF508 mutant. N-butyl deoxynojirimycin had an EC50 of 123 mu M for restoring iodide efflux in CF15 human lung epithelial cells (which are homozygotic for the delF508 mutation) after stimulation with forskoline and genisteine.
Patent IL-176838-A0 (IL)
Title: Method and device for treating contaminated water
IPC: B01D1/30
Filed: 2006-07-13
Abstract: The invention relates to a method and a device for treating contaminated water in a steam power installation, and to a corresponding steam power installation. According to the invention, steam and water are separated between a first steam-collecting drum of a pressure level and a second steam-collecting drum of a lower pressure level.
Patent IL-178587-A0 (IL)
Title: Medical diagnostic system
IPC: G01N27/333
Filed: 2006-10-15
Abstract: A system for conducting a plurality of different medical diagnostic tests comprises a hand-held portable self contained instrument for engaging a disposable test cell containing a fluid to be tested. The instrument performs a diagnostic test selected from the plurality of tests upon the fluid within the test cell, the test being selected by the instrument based upon identification information obtained from the test cell. A disposable, single use test cell is provided for receiving fluid to be diagnostically tested. The test cell includes identification information indicative of a particular test to be performed upon the fluid, the test cell being sized and shaped for engagement by the instrument.
Patent RO-133845-A0 (RO)
Title: Centrifugal compressor rotary assembly made of advanced composite polymeric materials reinforced with carbon fibers
Inventor: VINTILĂ SEBASTIAN IONUŢ
IPC: F01D11/10
Filed: 2019-09-12
Abstract: The invention relates to a centrifugal compressor rotary assembly made of advanced polymeric composites reinforced with carbon fibers, meant for turbo-jet engines used in aerospace field or in terrestrial applications requiring a certain flow-rate and pressure of air. According to the invention, the assembly consists of a transmission shaft (1) which, by means of a driving shaft (4), transfers the engine rotation movement to a rotor (2) provided with a disk (7) and some blades (3), the profile of the disk (7) comprising nine layers (9, 10 and 11) of bidirectional carbon fibre cloth of fundamental twill type, pre-impregnated with epoxy resin, having a specific weight of 200 g/m, 42% epoxy matrix, the layers (9, 10 and 11) being arranged according to the sequential arrangement [0°, 45°, 90°], and the profile of the blade (3) and a flowing channel (8) are formed of six layers (9) of bidirectional carbon fibre cloth of fundamental twill type, pre-impregnated with epoxy resin, arranged according to the sequential arrangement [0°], and, in the composite polymeric material reinforced with carbon fibers there is provided a metallic hub (5) consisting of a K-profile metallic bush in the center of the rotor (2), to engage the driving shaft (4), the geometry of the K-profile metallic hub (5) within the rotor (2) being similar to that of the driving shaft (4), which is made on the entire depth, by machining.
Patent RO-135569-A0 (RO)
Title: Preparations of natural products used for treating mastitis with bacterial etiology
Inventor: TULCAN CAMELIA
IPC: A61P31/02
Filed: 2021-09-22
Abstract: The invention relates to a preparation made of natural products for the treatment of mastitis with bacterial etiology. According to the invention, the preparation consists of a complex I of basil extract and marigold extract, in a mass ratio of 1: 2, possibly a complex II of extracts of sage, celandine, wild garlic and artichoke, in equal mass ratios, a complex III from extracts of marigold, wild garlic, artichoke, common hedgenettle and tagetes, in a mass ratio of 3:1:1:1:1, in combination with an incorporation base of wool grease type, oils and natural adjuvants.
Patent MA-38155-A1 (MA)
Title: Utilisation du pidotimod pour traiter le psoriasis
Inventor: MAILLAND FEDERICO
IPC: A61P17/06
Filed: 2012-12-19
Abstract: La présente invention porte sur l'utilisation du pidotimod ou de son sel physiologiquement acceptable pour traiter le psoriasis. Dans l'invention, le pidotimod ou son sel physiologiquement acceptable peut être administré par voie systémique ou topique pour traiter le psoriasis.
Patent MA-38601-A1 (MA)
Title: Poulie améliorée pour treuil à haut rendement
Inventor: IPPOLITO MASSIMO
IPC: B66D1/74
Filed: 2014-03-26
Abstract: Poulie (2) améliorée destinée à un treuil, laquelle poulie se trouve en contact avec au moins une section de câble (1) comprise entre une section d'entrée (11), reliée à une charge de travail, et une section de sortie (12), avec une tension minimum ou nulle, ladite poulie (2) comprenant une chaîne cinématique composée de supports périphériques (3).
Patent MA-38682-A1 (MA)
Title: Dispositif de correction de l'angle d'une échelle par rapport au sol
Inventor: ZERZOURI OMAR
IPC: E06C5/36
Filed: 2015-12-16
Abstract: Il s'agit d'un dispositif de correction de l'angle optimal d'une échelle par rapport au sol pour respecter les consignes de sécurité en vigueur. Le dispositif est doté d'un capteur électrique de mesure de l'angle de l'échelle par rapport au sol, associé à un microprocesseur qui traite cette donnée en fonction de la nature du sol et la taille de l'échelle et lance par la suite un signal sonore avec un témoin lumineux si l'angle mésuré correspond à l'angle de sécurité. L'invention apporte une solution à la minimisation des risques d'accidents causés par le non respect des consignes de sécurité dans la pose de l'échelle et plus précisément l'angle de cette dérnière par rapport au sol.
Patent MA-38835-A1 (MA)
Title: Destruction d'aiguille hypodermique
Inventor: KIRBY CLIFFORD
IPC: A61M5/32
Filed: 2014-07-14
Abstract: La présente invention concerne un appareil de traitement d'une aiguille hypodermique, comprenant : un cylindre de confinement destiné à recevoir l'aiguille ; une première électrode destinée à entrer en contact avec l'aiguille à proximité d'une première extrémité ; une seconde électrode destinée à entrer en contact avec l'aiguille au niveau de son extrémité affûtée ; un système de commande, pouvant fonctionner pour provoquer l'écoulement d'un courant dans l'aiguille entre lesdites première et seconde électrodes, ledit courant entraînant ainsi l'assouplissement de l'aiguille et la seconde électrode étant configurée pour se déplacer à l'intérieur du cylindre de confinement et pour fournir une force de compression à l'aiguille, le cylindre de confinement étant configuré pour être chauffé durant le traitement.
Patent MA-51974-A1 (MA)
Title: Molécules hétérocycliques à motifs pyrazole et benzimidazole et leurs propriétés biologiques
Inventor: BOUHFID RACHID
IPC: C07D401/14
Filed: 2020-12-29
Abstract: Cette invention concerne la synthèse de nouvelles molécules hétérocycliques contenant une jonction carbonyle attachée au noyau 1-benzyl-1h-benzimidazole et au noyau 1-benzyl-3- methyl-1h-pyrazole via trois étapes de synthèse. Dans un premier temps, la synthèse de (z)-1- benzyl-4-(2-oxopropylidène)-1,3,4,5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one (2a) par une réaction d'alkylation de la molécule de départ 4z-(2- oxopropylidène)-1,2,4,5-tétrahydro-1h- 1,5-benzodiazépine-2-one (1) avec le bromure de benzyle dans les conditions de la catalyse par transfert de phase (ctp). Dans un deuxième temps, la synthèse du 1-benzyl-2-((5-methyl-1hpyrazol- 3-yl)méthyl)-1h-benzimidazole (3) par la condensation du composé (2) avec l’hydrazine monohydrate à reflux de méthanol. Puis, la synthèse des molécules (4-5) en utilisant la méthode ctp.